Recruiting

A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(20 sites)

United States

Trinity Research Group /ID# 279914, Dothan, Alabama

Arizona Eye Center - West Ray Road /ID# 267993, Chandler, Arizona

Canyon City Eyecare /ID# 267948, Azusa, California

Global Research Management /ID# 267980, Glendale, California

Lakeside Vision Center /ID# 268544, Irvine, California

Eye Research Foundation /ID# 267931, Newport Beach, California

Lee Shettle Eye and Hearing /ID# 268118, Largo, Florida

Clayton Eye Center /ID# 268097, Morrow, Georgia

Coastal Research Associates - Roswell /ID# 279915, Roswell, Georgia

Kannarr Eye Care /ID# 267979, Pittsburg, Kansas

Butchertown Clinical Trials /ID# 267887, Louisville, Kentucky

Moyes Eye Centers /ID# 267944, Kansas City, Missouri

Northern New Jersey Eye Institute /ID# 267974, South Orange, New Jersey

Rochester Ophthalmological Group - Rochester /ID# 268374, Rochester, New York

Core Inc /ID# 267946, Shelby, North Carolina

Scott and Christie and Associates /ID# 268119, Cranberry Township, Pennsylvania

Southern College of Optometry /ID# 267971, Memphis, Tennessee

Total Eye Care - Memphis /ID# 268327, Memphis, Tennessee

Advancing Vision Research - Smyrna - Stonecrest Parkway /ID# 267939, Smyrna, Tennessee

Piedmont Eye Center /ID# 267929, Lynchburg, Virginia